Monday, December 09, 2019 5:12:21 PM
Is anyone else concerned that the futility statement is due out this month and the stock price is tanking? Are the insiders selling because they know the futility statement will be bad? It doesn't appear that way due to the volume, it could be declining because people are waiting to see if they will buy until the futility statement comes out? Thoughts?
The majority of the potential behind this stock is in relation to the keytruda birinapant study, granted there are a total of 3 trials currently with birinapant including the promising Stanford trial, however we all know that the real money, billions is tied to the immune therapy trial with keytruda, that would almost double the current market size of keytruda and in time it would surpass the lung cancer sales for the drug as colon cancer is quickly approaching lung cancer in terms of dx's.
Thoughts?
Is the declining stock price an intentional move? I noticed the volume being sold is negligible or is it panic?
I guess we will see in less then 3 weeks.
Good Luck to everyone.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM